Building a Semaglutide-Friendly Plate Instead of focusing on what not to eat, shift your mindset toward building meals that work with semaglutide
As reported in the phase 3 SURPASS trial on PubMed [3] , tirzepatide demonstrated significant, dose-dependent reductions in HbA1c, fasting insulin, and body weight over 52 weeks
People who have experienced tirzepatide diarrhea or tirzepatide constipation already know these side effects can be difficult to manage
Patients should ask what form is being used (base versus salt forms for semaglutide), and understand FDA warnings about compounded GLP-1 products
Research on bone health during Retatrutide treatment remains limited, though data from similar medications suggests modest bone density decreases during active weight loss phases
Like Mounjaro, it reduces caloric intake through GLP-1 and GIP receptor activation